Chondroitin Sulphate Market Size & Share 2026-2035

Chondroitin Sulphate Market Size

The global chondroitin sulphate market was valued at USD 1.5 billion in 2025 and is poised to expand from USD 1.53 billion in 2026 to USD 2.4 billion by 2035, reflecting a 5.3% CAGR over 2026 to 2035 according to the latest report published by Global Market Insights Inc.

• The chondroitin sulphate market is experiencing significant business and industry trends driven by increasing consumer awareness of joint health, particularly among aging populations and pet owners. The growing prevalence of osteoarthritis and other joint-related disorders is fueling demand for dietary supplements and functional foods that include chondroitin sulfate, as consumers seek effective solutions for pain management and improved mobility.
   
• Additionally, there is a notable shift toward natural and plant-based sources of chondroitin sulfate, spurred by rising interest in sustainable and ethical products. This trend is accompanied by advancements in extraction and production techniques, particularly microbial fermentation, which provides an environmentally friendly alternative to traditional animal-derived sources
   
• Furthermore, the pet supplement market is witnessing robust growth, with chondroitin sulfate becoming increasingly common in formulations aimed at enhancing the health and well-being of pets, especially aging dogs and horses. E-commerce is also playing a crucial role in market expansion, allowing consumers to access a wider range of chondroitin sulfate products conveniently.
   
• Looking ahead, the industry is expected to focus on innovation, regulatory compliance, and effective marketing strategies to meet evolving consumer demands while ensuring product safety and efficacy
   

Chondroitin Sulphate Market Trends

• The rising elderly population is a significant growth driver for the chondroitin sulfate market, as aging is closely associated with joint degeneration and conditions like osteoarthritis. As people age, the body's natural production of chondroitin sulfate, a key component of cartilage, declines, leading to joint stiffness, pain, and reduced mobility.
   
• This creates a growing demand for joint health supplements, with chondroitin sulfate being one of the most popular ingredients for managing and preventing such conditions. In fact, osteoarthritis, the most common form of arthritis, disproportionately affects older adults, and with the global elderly population steadily increasing, the market for products addressing this issue is expanding.
   
• For instance, according to the World Health Organization (WHO), the number of people aged 60 and older is expected to double by 2050, reaching over 2 billion. This demographic shift is particularly pronounced in regions like North America, Europe, and parts of Asia, where healthcare systems and consumers are increasingly focused on improving the quality of life through preventive measures. Chondroitin sulfate supplements, often combined with other ingredients like glucosamine, are widely recommended to help slow down cartilage breakdown and maintain joint function, making them an essential part of the regimen for aging individuals.
   
• The rising prevalence of osteoarthritis is a significant driver for the chondroitin sulfate market growth. Osteoarthritis, a degenerative joint disease, affects millions of people worldwide, especially the aging population. As global life expectancy increases, the number of individuals suffering from osteoarthritis is expected to rise, driving demand for joint health supplements and treatments.
   
• Chondroitin sulfate, often used in combination with glucosamine, is recognized for its potential to alleviate osteoarthritis symptoms, including pain, inflammation, and cartilage degradation. It works by retaining water in cartilage, improving its elasticity, and potentially slowing joint deterioration. With osteoarthritis being a chronic and non-curable condition, many patients turn to long-term, non-pharmaceutical options like chondroitin sulfate to manage their symptoms and improve their quality of life.
   
• The increasing awareness among patients and healthcare providers about the benefits of chondroitin sulfate as a safer, natural alternative to pain relievers and non-steroidal anti-inflammatory drugs (NSAIDs) further boosts market growth. Unlike NSAIDs, which can cause adverse side effects with prolonged use, chondroitin sulfate is viewed as a safer option for long-term joint health management. This appeals to consumers seeking preventative measures or osteoarthritis relief without the risks associated with pharmaceutical drugs
   

Chondroitin Sulphate Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on source the market is segmented as bovine, porcine, avian, marine, others.
 

• Bovine captured roughly 39.3% of the market share in 2025. Chondroitin sulfate from bovine sources is a naturally occurring glycosaminoglycan extracted primarily from the cartilage of cows. It is widely used for its therapeutic properties, particularly in joint health supplements, where it helps maintain cartilage integrity, reduce inflammation, and improve mobility, especially in people with osteoarthritis.
   
• Bovine-sourced chondroitin is known for its high quality and bioavailability, making it a preferred choice in pharmaceutical and nutraceutical applications. Its widespread use in dietary supplements, often in combination with glucosamine, has driven its market growth, particularly in regions like North America and Europe, where aging populations are increasingly focusing on preventive healthcare solutions. Current market trends show rising consumer demand for natural and effective joint health products, along with a growing preference for animal-based chondroitin due to its established efficacy.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on form the market is segmented as powder, capsule/tablets, and liquid.
 

• Powder represented about 55.9% of the chondroitin sulphate market in 2025. The powder form of chondroitin sulfate is gaining popularity due to its versatility and ease of use in various applications. Current trends show increased demand for powdered chondroitin sulfate in dietary supplements, as consumers prefer convenient and customizable formats that integrate easily into daily routines. This trend aligns with growing interest in clean-label products, with manufacturers highlighting the purity and quality of their ingredients. The powdered form also allows for effective dosage adjustment, meeting individual health requirements. As health awareness rises, the powdered chondroitin sulfate market is expected to grow, particularly among fitness enthusiasts and older populations seeking joint support.
   
• Capsules and tablets are common forms of chondroitin sulfate dietary supplements, mainly used for joint health support and osteoarthritis symptom management. These solid forms contain chondroitin sulfate from various sources, including cows, pigs, marine animals, and synthetic options. People like capsules and tablets because they are easy to use, provide exact doses, and last a long time.
   

Looking for region specific data?

Download Free PDF

The U.S. chondroitin sulphate market valued at USD 464.4 million in 2025 and estimated to grow to almost USD 755.1 million by 2035. North America holds around 38.2% of the market share in 2025.
 

• In North America, particularly in the U.S. and Canada, the chondroitin sulphate industry is experiencing robust growth. This expansion is driven by increasing consumer awareness of joint health and the prevalence of osteoarthritis among the aging population. The U.S. market dominates, fueled by strong demand for dietary supplements that promote joint health, often combined with glucosamine and other complementary ingredients. Current market trends indicate a shift towards clean-label products, with consumers seeking transparency in sourcing and manufacturing processes. This has led manufacturers to prioritize high-quality, sustainably sourced chondroitin sulfate, enhancing product appeal among health-conscious consumers. The rise of e-commerce platforms also plays a crucial role in expanding market reach, making chondroitin sulfate products more accessible to a wider audience.
   
• The chondroitin sulfate market in Europe, particularly in Germany, and UK is experiencing significant growth driven by an aging population and rising health awareness. In Germany, there is a robust demand for joint health supplements as consumers increasingly seek preventive measures against conditions like osteoarthritis. The UK market is witnessing a surge in the popularity of dietary supplements containing chondroitin sulfate, supported by extensive research highlighting its benefits for joint mobility. France has seen a growing trend towards natural and organic products, leading to increased interest in chondroitin sulfate derived from sustainable sources.
   
• In Asia Pacific, there is a strong demand for dietary supplements that promote joint health, with chondroitin sulfate being widely recognized for its effectiveness in treating osteoarthritis and other joint-related conditions. China is emerging as a significant market due to rising disposable incomes and a shift towards preventive healthcare, leading to increased consumption of health supplements, including chondroitin sulfate. In India, the market is expanding rapidly, fueled by growing awareness of nutritional products and the rising prevalence of joint disorders.
   

Chondroitin Sulphate Market Share

The chondroitin sulphate industry is consolidated, with the top five players (Synutra Ingredients, Yantai Dongcheng Pharmaceutical Group, Shandong Runxin Biotechnology, Merck KGaA, Seikagaku Corporation) holding 46% combined share in 2025 and a long tail of specialized producers, research spin-outs, and regional entrants. These companies have gained market leadership through a combination of trusted brand presence and robust product portfolios catering to diverse sectors such as pharmaceuticals, dietary supplements, and veterinary medicine.
 

Key players in the chondroitin sulfate industry have invested significantly in research and development to enhance product efficacy, ensure compliance with regulatory standards, and meet the evolving needs of customers. For instance, Merck KGaA has advanced its product offerings in high-purity chondroitin sulfate to serve the pharmaceutical and nutraceutical markets. Similarly, Seikagaku Corporation is recognized for its commitment to quality, often using state-of-the-art manufacturing processes that ensure high purity and consistency in their chondroitin sulfate products.
 

• Merck KGaA
  • Merck’s Millipore (Life Science) division supplies high-purity chondroitin sulfate—commonly derived from bovine cartilage—as raw materials and certified standards for pharmaceutical, biotech, and research applications. Their products include pharmaceutical-grade sodium chondroitin sulfate salts meeting USP/EP specifications, supported by technical documentation (COA/COQ), emphasizing high quality and regulatory compliance
     

• Shandong Runxin Biotechnology
  • Founded in 1998 in Qufu, Shandong Runxin is a dedicated manufacturer of bio-medical ingredients, specializing in chondroitin sulfate and sodium hyaluronate. The company operates on a 20,000 m² site with cGMP, ISO, HACCP, FSSC, HALAL certifications, offering multiple grades—from food and cosmetic to injectable and pharmaceutical—sourced from diverse animals and even non-animal (fermented) origins, and exports to over 70 countries
     
• Seikagaku Corporation
  • Seikagaku pioneered the first commercial production of sodium chondroitin sulfate in 1950, leveraging proprietary extraction and purification methods. Their product line includes medical-grade chondroitin sulfate for injectables and eye-drops (Japanese Pharmaceutical Codex compliant, ~20–40 kDa). The company is a glycoscience-focused pharmaceutical R&D leader, reinvesting over 25 % of revenues into new drug discovery
     

Chondroitin Sulphate Market Companies

Major players operating in the chondroitin sulphate industry are:
 

• TSI Group Ltd.
• Synutra Ingredients (Shandong) Co., Ltd.
• Yantai Dongcheng Pharmaceutical Group Co., Ltd.
• Jiaxing Hengjie Biopharmaceutical Co., Ltd.
• Qufu Liyang Biochem Industrial Co., Ltd.
• Pacific Rainbow International, Inc.
• Shandong Runxin Biotechnology Co., Ltd.
• ZPD A/S
• Guangdong Hybribio Biotech Co., Ltd.
• Wanbury Limited
• Sierra Ingredients Pty Ltd.
• BGM Pharmaceuticals Co., Ltd.
• YBCC (Qingdao) Co., Ltd.
• Anhui Jintung Fine Chemical Corporation Ltd.
   

Chondroitin Sulphate Industry News

• In April 2025, Gnosis by Lesaffre rebranded its fermentation-derived chondroitin sulfate from Mythocondro® to MyCondro™, introducing a new logo and branding aimed at emphasizing its animal-free, high-bioavailability formulation
   
• In March 2025, Qingdao Longchem Biotechnology Co., Ltd. partnered with SGS to establish a joint laboratory dedicated to high-standard testing and quality assurance of chondroitin sulfate and related feed additives.
   
• In January 2024, Shandong Guanghao Biological Products Co., Ltd., a leading manufacturer, entered a strategic distribution partnership with Qingdao Longchem Pharmachem Co., Ltd., making Longchem its exclusive global distributor in January 2024.
   

The chondroitin sulphate market research report includes in-depth coverage of the industry, with estimates & forecast in terms of revenue (USD Million) and volume (Kilo Tons) from 2022 to 2035, for the following segments:

Click here to Buy Section of this Report

Market, By Source

• Bovine
• Porcine
• Avian
  • Chicken
  • Turkey
  • Others 
• Marine
  • Tuna
  • Salmon
  • Others
• Others

Market, By Form

• Powder
• Capsule/Tablets
• Liquid

Market, By Application

• Dietary Supplements
  • Capsules
  • Tablets
  • Gummies 
• Pharmaceuticals
  • Osteoarthritis treatment drugs
  • Joint health formulations
• Cosmetic and Personal Care
  • Anti-aging creams
  • Skin hydration products
• Food and Beverages
• Others

Market, By Distribution Channel

• Direct Sales
• Distributors
• Online Retail
• Pharmacies

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa